Abstract:Background/aims: Avascular necrosis of the femoral head (ANFH) is the focus and difficulty of orthopedic diseases. Recently, tissue engineering bone for this disease has shown a good therapeutic effect. The aim of the present study was to investigate the therapeutic effect of basic fibroblast growth factor (FGF-2) as cytokines transfected bone marrow mesenchymal stem cells (BMSCs) in constructing tissue-engineered bone for avascular necrosis of the femoral head. Methods: The FGF-2 gene overexpressed lentivirus-transfected rBMSCs with xenogeneic antigen-extracted cancellous bone (XACB) to construct tissue engineered bone, and the model of early avascular necrosis of the femoral head was established by lipopolysaccharide (LPS) combined with hormone. The models were randomly divided into five groups: A (control), B (XACB), C (XACB+rBMSCs), D (XACB+rBMSCs+Lv-GFP), and E (XACB+rBMSCs+Lv-FGF-2/GFP) groups. The therapeutic effect of the tissue engineered bone for the avascular necrosis of the femoral head was evaluated by gross anatomy, X-ray examination, immunohistochemistry and H&E staining. Results: The FGF-2 gene was transfected into rBMSCs (Multiplicity of infection [MOI] = 100) by lentivirus, and its efficiency was above 95%. The rBMSCs were successfully transfected overexpressing FGF-2 by qPCR and western blot. After tissue engineering bone implantation, X-ray examination and gross specimen observation revealed that the repair area in the E group was > 80% at six weeks, the defect was completely repaired at 12 weeks, and osteogenesis was stronger, when compared with the other groups. For the X-ray score, vascular area density and new bone formation area were higher, when compared with the other groups, and the difference was statistically significant (P< 0.05). Conclusion: FGF-2 gene overexpression lentivirus transfection BMSCs combined with XACB to construct tissue engineered bone can effectively promote vascular regeneration, and improve the repair effect of avascular necrosis of the femoral head.

Experimental Study of Vascular Endothelial Growth Factor Gene Therapy for Avascular Necrosis of the Femoral Head

Vascular Endothelial Growth Factor Gene Transfection to Enhance the Repair of Avascular Necrosis of the Femoral Head of Rabbit.

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Treatment of avascular necrosis of the femoral head with VEGF165 gene

Deproteinized bone with VEGF gene transfer to facilitate the repair of early avascular necrosis of femoral head of rabbit.

Deproteinized bone with VEGF gene transfer for avascular necrosis of the femoral head

Intramuscular administration of vascular endothelial growth factor augmenting collateral circulation in a rat hindlimb replantation model.

REPAIR OF EARLY AVASCULAR NECROSIS OF FEMORAL HEAD BY USING DEPROTEINIZED BONE WITH VASCULAR ENDOTHELIAL GROWTH FACTOR GENE TRANSFER IN RABBITS

Intramuscular Administration of Vascular Endothelial Growth Factor Augmenting Collateral Circulation in a Rat Hindlimb Replantation Model

The effects of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes in steroids-induced avascular necrosis of femoral head

Experimental Study of Vascular Endothelial Growth Factor Gene Transfection to Promote Wound Healing

Treatment of osteonecrosis of the femoral head with hVEGF-165-gene- modified mesenchymal stem cells in mongrel dogs

Angiopoiesis and Bone Regeneration Via Co-Expression of the Hvegf and Hbmp Genes from an Adeno-Associated Viral Vector in Vitro and in Vivo.

Role of FGF-2 Transfected Bone Marrow Mesenchymal Stem Cells in Engineered Bone Tissue for Repair of Avascular Necrosis of Femoral Head in Rabbits

An Experimental Study of Interventional Therapy by Direct Puncture for the Treatment of Hormone-Induced Necrosis of Femoral Head

"Molecular Bypass": The Application of vascular endothelial growth factor to gene therapy of experimental limb ischemia

Repair effect of coexpression of the hVEGF and hBMP genes via an adeno-associated virus vector in a rabbit model of early steroid-induced avascular necrosis of the femoral head

Treatment of rabbit femoral head necrosis with polylactic acid/hydroxyapatite porous scaffold combined with rabbit bone marrow mesenchymal stem cells transfected by vascular endothelial growth factor

[Treatment of Early Avascular Necrosis of Femoral Head by Core Decompression and Transplantation of Human Hepatic Growth Factor Gene-Modified Osteoblasts: Experiment with Rabbits].

Repair effects of co-expression of the VEGF and BMP genes via an adeno-associated viral vector on early steroid-in-duced avascular necrosis of the femoral head in rabbits

An Experimental Study Of Transfection Of A Vegf Plasmid Carried By An Ultrasound Microbubble Contrast Agent In Rats With Steroid-Induced Osteonecrosis Of Femoral Head